A pioneering approach is offering researchers new insights into why some prostate cancers are more aggressive and difficult to treat.
In a new application to prostate cancer research, Vancouver Coastal Health Research Institute scientists have used a sequencing technique – called plasma cell-free chromatin immunoprecipitation sequencing (cfChIP-seq) – on blood samples from patients with advanced disease, revealing biological factors that may drive disease progression.
